These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24918153)

  • 1. Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes.
    Roy MS; Janal MN; Crosby J; Donnelly R
    Kidney Int; 2015 Feb; 87(2):427-33. PubMed ID: 24918153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma markers of inflammation and prediction of cardiovascular disease and mortality in African Americans with type 1 diabetes.
    Roy MS; Janal MN; Crosby J; Donnelly R
    Diabetes Res Clin Pract; 2016 Apr; 114():117-25. PubMed ID: 26806456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.
    Roy MS; Janal MN; Crosby J; Donnelly R
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5471-80. PubMed ID: 23847308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.
    Lin J; Glynn RJ; Rifai N; Manson JE; Ridker PM; Nathan DM; Schaumberg DA
    Diabetes Care; 2008 Dec; 31(12):2338-43. PubMed ID: 18796620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy.
    Kolseth IB; Reine TM; Parker K; Sudworth A; Witczak BJ; Jenssen TG; Kolset SO
    J Diabetes Complications; 2017 Jan; 31(1):245-252. PubMed ID: 27452162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
    Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy.
    Clausen P; Jacobsen P; Rossing K; Jensen JS; Parving HH; Feldt-Rasmussen B
    Diabet Med; 2000 Sep; 17(9):644-9. PubMed ID: 11051283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year incidence of proteinuria in type 1 diabetic African Americans.
    Roy MS; Affouf M; Roy A
    Diabetes Care; 2007 Jul; 30(7):1807-12. PubMed ID: 17475942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
    Persson F; Rossing P; Hovind P; Stehouwer CD; Schalkwijk CG; Tarnow L; Parving HH
    Scand J Clin Lab Invest; 2008; 68(8):731-8. PubMed ID: 18609080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes.
    Goldschmid MG; Domin WS; Ziemer DC; Gallina DL; Phillips LS
    Diabetes Care; 1995 Jul; 18(7):955-61. PubMed ID: 7555556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
    Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
    Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiorenal syndrome in type 1 diabetes mellitus: the role of endothelial dysfunction].
    Shestakova MV; Iarek-Martynova IR; Ivanishina NS; Aleksandrov AA; Dedov II
    Kardiologiia; 2005; 45(6):35-41. PubMed ID: 16007033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
    Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
    von Scholten BJ; Reinhard H; Hansen TW; Schalkwijk CG; Stehouwer C; Parving HH; Jacobsen PK; Rossing P
    J Diabetes Complications; 2016 Mar; 30(2):248-55. PubMed ID: 26651261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus.
    Polat SB; Ugurlu N; Aslan N; Cuhaci N; Ersoy R; Cakir B
    Arch Endocrinol Metab; 2016 Apr; 60(2):117-24. PubMed ID: 26886090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic renal disease in African Americans.
    Crook ED
    Am J Med Sci; 2002 Feb; 323(2):78-84. PubMed ID: 11863083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
    Baker NL; Hunt KJ; Stevens DR; Jarai G; Rosen GD; Klein RL; Virella G; Lopes-Virella MF;
    Diabetes Care; 2018 Jan; 41(1):128-135. PubMed ID: 29118060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing natural history of nephropathy in type I diabetes.
    Krolewski AS; Warram JH; Christlieb AR; Busick EJ; Kahn CR
    Am J Med; 1985 May; 78(5):785-94. PubMed ID: 3993659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.